Novartis India (@NovartisIndia) header
Novartis India (@NovartisIndia) profile picture

Reimagining medicine in India since 1947. Our people make us a Great Place to Work 2026®. https://teapawt.org/t.co/ryVPXwOJVM

India
Joined September 2019
Photo by Novartis India (@NovartisIndia)Photo by Novartis India (@NovartisIndia)Photo by Novartis India (@NovartisIndia)Photo by Novartis India (@NovartisIndia)Photo by Novartis India (@NovartisIndia)Photo by Novartis India (@NovartisIndia)Photo by Novartis India (@NovartisIndia)Photo by Novartis India (@NovartisIndia)Photo by Novartis India (@NovartisIndia)Photo by Novartis India (@NovartisIndia)
True innovation takes shape when academia and industry come together to solve real‑world challenges. 𝗡𝗘𝗦𝗧 𝟮.𝟬 (𝗡𝘂𝗿𝘁𝘂𝗿𝗶𝗻𝗴 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲, 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝗶𝗻𝗴 𝗧𝗮𝗹𝗲𝗻𝘁), an initiative by the Novartis Development India Hub, built on the foundation of its first edition, evolved into a more partnership‑driven platform rooted in collaboration and co‑creation with academic institutions. Over several months, the initiative engaged students and faculty across India, starting with campus interactions where leaders from the Novartis Development India Hub connected directly with young talent. These engagements enabled problem‑solving at the intersection of academic thinking and real‑world healthcare needs. The scale was significant: 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝗳𝗿𝗼𝗺 𝗼𝘃𝗲𝗿 𝟳,𝟬𝟬𝟬 𝗰𝗼𝗹𝗹𝗲𝗴𝗲𝘀 𝗮𝗻𝗱 𝟯𝟯,𝟬𝟬𝟬+ 𝗶𝗻𝗱𝗶𝘃𝗶𝗱𝘂𝗮𝗹 𝗿𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝟮𝟰,𝟬𝟬𝟬+ 𝘁𝗲𝗮𝗺𝘀, but the impact went far beyond numbers. Supported by faculty mentors and Novartis experts, students developed solutions grounded in responsible innovation and practical relevance. In the Grand Finale held over two days at the Novartis Corporate Center in Hyderabad, 𝘀𝗶𝘅 𝘁𝗲𝗮𝗺𝘀 - 𝘁𝗵𝗿𝗲𝗲 𝘄𝗶𝗻𝗻𝗲𝗿𝘀 𝗮𝗻𝗱 𝘁𝗵𝗿𝗲𝗲 𝗿𝘂𝗻𝗻𝗲𝗿𝘀 𝘂𝗽 𝘄𝗲𝗿𝗲 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘀𝗲𝗱 for applying AI, advanced analytics, and digital technologies to make processes across clinical trials, patient safety, and technical R&D more intelligent and efficient. The journey reaffirmed our belief in India’s next generation of innovators, reflected in the depth of talent and quality of ideas on display. At Novartis, initiatives like NEST reflect our long‑term commitment to 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗮 𝗮𝗻𝗱 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆, strengthening talent ecosystems, and nurturing a 𝗯𝗼𝗹𝗱, 𝗿𝗲𝘀𝗶𝗹𝗶𝗲𝗻𝘁 𝘄𝗼𝗿𝗸𝗳𝗼𝗿𝗰𝗲 ready to shape the future of healthcare innovation. Tune into the NEST 2.0 special on CNBC-TV18 airing at 5pm IST this Saturday, with a repeat at 3:30pm IST this Sunday. #NESTbyNovartis #NovartisDevelopmentIndiaHub #ReimaginingMedicine #HealthcareInnovation #AcademicPartnerships #25YearsofNOCCinIndia
1
1
3
607
𝗪𝗲𝗹𝗹𝗯𝗲𝗶𝗻𝗴 𝗶𝘀 𝗻𝗼𝘁 𝘀𝗶𝗺𝗽𝗹𝘆 𝗮𝗯𝗼𝘂𝘁 𝘁𝗮𝗸𝗶𝗻𝗴 𝗮 𝗽𝗮𝘂𝘀𝗲. 𝗜𝘁 𝗶𝘀 𝗮𝗯𝗼𝘂𝘁 𝗯𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝘀𝘁𝗿𝗲𝗻𝗴𝘁𝗵 𝘁𝗼 𝗸𝗲𝗲𝗽 𝗺𝗼𝘃𝗶𝗻𝗴 𝗳𝗼𝗿𝘄𝗮𝗿𝗱. 𝗔𝗻𝗱 𝘄𝗲 𝗮𝗿𝗲 𝗴𝗿𝗮𝘁𝗲𝗳𝘂𝗹 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗽𝗲𝗼𝗽𝗹𝗲 𝘄𝗵𝗼 𝗵𝗲𝗹𝗽 𝘂𝘀 𝘀𝗲𝗲 𝘄𝗵𝗮𝘁 𝘁𝗵𝗮𝘁 𝗰𝗮𝗻 𝗹𝗼𝗼𝗸 𝗹𝗶𝗸𝗲 𝗶𝗻 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲. Sometimes, the most powerful lessons in wellbeing come from those who have had to practice resilience every single day. During her visit to NOCC Hyderabad, @NSaina took us beyond the achievements and into the journey behind them. She spoke about what competing at the highest level has taught her about discipline, recovery and resilience, but also about the hard work and determination it takes to pursue a goal and remain committed to it when the path gets tough. Her message was simple and powerful: lead yourself first. Set a goal, work hard towards it and keep pushing. But stay humble enough to learn, surround yourself with your ‘A team’, and recognize that the people who challenge, coach and support you are an important part of the journey. There were plenty of lighter moments too. As Saina reminisced about her journey, she shared memories and experiences that brought laughter into the room and gave us a glimpse of the person behind the champion. Her reflections were a reminder that being at our best is not about constantly doing more. It is about bringing determination and wellbeing together, having the humility to keep learning, knowing when to push forward and when to recover, and valuing the people who help us become better along the way. That is the culture of care we continue to build at Novartis: one where wellbeing helps our people thrive and, in turn, create greater impact. Thank you, Saina, for sharing your time, your journey and your experiences with such openness and warmth. We are grateful for a conversation that left us inspired, gave us much to reflect on and brought plenty of smiles along the way. #WellbeingAtWork #CultureOfCare #NovartisIndia #NOCC
1
9
648
Bold science requires bold thinking, deep collaboration, and the capabilities to turn possibility into progress for patients. Fiona Marshall’s visit to Novartis India offered a chance to reflect on Novartis Biomedical Research’s ambition and India’s vital role in that global mission. Our team in India is making a real difference across our global network, thanks to our advanced scientific capabilities and collaboration across BR and beyond. With growing strengths in early discovery, translational sciences, biomarker research, clinical pharmacology and mathematical modelling, all boosted by AI and digital, our teams are tackling tough scientific questions in novel ways.  Moreover, progress reaches beyond our walls. Fiona’s conversations with industry and academic leaders highlighted how partnerships across the innovation ecosystem spark ideas, advance science and open new possibilities.
1
1
130
The visit also provided an important moment to reflect on the role of technology in our work. As we become more fluent in an AI-enabled world, being human and bringing empathy to how we work with one another matters more than ever. It was wonderful to have Fiona with us and to reflect on the opportunity to bring together the best of our science, people, technology and partnerships to create greater impact for patients around the world. #BiomedicalResearch #NovartisIndia #Innovation
78
When we stay connected to why our work matters, we can multiply our impact. That was one of the many reflections @VasNarasimhan shared during his time with us in India as we celebrate 25 years of Novartis Corporate Centre (NOCC) in India. Across conversations with our teams at the NOCC in Hyderabad, Vas brought us back to a simple but powerful idea: purpose gives us perspective and that each of us has the opportunity to multiply our individual and collective impact. At our all-associate town hall, that perspective broadened further. Today, our innovative medicines reach more than 300 million patients, while our purpose also takes us into areas of profound unmet need, including our continued work in public health in malaria and leprosy.
1
3
229
Sharing his own career journey, Vas reflected on how his passion for public health once led him to take a different path to pursue work he deeply believed in. A reminder that careers are shaped not only by the roles we take on, but by the impact we choose to pursue. And as AI transforms the world around us, his challenge to us was equally clear: embrace its possibilities, while continuing to strengthen what makes us distinctly human. Be courageous. Keep growing as people and leaders. And keep finding ways to multiply our impact. The transformational strategies we shape today have the potential to change what is possible for patients tomorrow.
1
1
91
Thank you, Vas, for the candour, perspective and ambition you brought to your time with us in India, and for reconnecting us with the purpose that unites us: reimagining medicine to improve and extend people’s lives. #NovartisIndia #ReimaginingMedicine #Leadership #Purpose
1
62
25 years. Countless milestones. One shared purpose: delivering for patients. As we mark 25 years of the Novartis Operations Corporate Center (NOCC) in Hyderabad, we were delighted to welcome Steffen Lang, President, Operations, Novartis, and Gabriella Messinese, Head of P&O Operations, to reflect on this important milestone and engage with associates across the organization. Over the past 25 years, Hyderabad has evolved significantly, building strong capabilities and playing a growing role in supporting @Novartis globally. The milestone is above all a reflection of the people who have shaped this journey and continue to move it forward. Today, Hyderabad brings together these capabilities across Operations, with quality, safety, reliable supply and support for key launches at the heart of what we do. Looking ahead, growing capabilities in AI, automation and digital technologies are creating new opportunities to strengthen how we work and deliver for patients.
1
1
148
A highlight was the time spent with colleagues across the site, hearing their questions, exchanging perspectives and sharing stories. The conversations really brought to life the energy and commitment of our Hyderabad community. Thank you, Steffen and Gabriella, for joining us for this special milestone. And to everyone who joined the conversations and shared their questions and ideas, thank you for making the engagement so memorable.
1
81
Strength, Resilience, and the Power to Take Charge. Every year, more than 2 lac women in India are estimated to be diagnosed with breast cancer, making it the most commonly diagnosed cancer among women in the country.¹ While early diagnosis can help save lifes, approx. 1 in 5 women having high-risk HR+/HER2- early breast cancer may be at a risk of recurrence i.e. their cancer may come back in 5 years.²⁻³ Hence, questions about the future, including the risk of recurrence, often remain. Staying informed, discussing treatment options with healthcare professionals that can reduce their risk of recurrence while maintaining quality of life can help patients navigate what comes next with greater confidence. Through Take Charge, Novartis supports patients with information and resources on early breast cancer, including understanding risk of recurrence, encourage informed discussions and shared decision-making. ▶️ Visit the Take Charge site to learn more: timesnownews.com/initiatives… #BCAM #TakeCharge #RoR #QoL Source: ¹ International Agency for Research on Cancer (IARC), GLOBOCAN India 2024., ² Saadatmand S, et al. BMJ. 2015;351:h4901.³ Crown J, et al. ESMO Open. 2025;105858. FA-11508330/15-09-2025 to 15-09-2027
1
111
BR India's RISING 2026 became a meeting point for bold ideas, breakthrough science, and the collaborations that could help shape the future of medicine. Bringing together researchers, scientists, innovators, and academic experts, BR Rising sparked conversations at the intersection of biomedical research, AI computational sciences, drug discovery, disease biology, translational science and emerging technologies. Across diverse topics and perspectives, a common theme emerged: the most meaningful breakthroughs happen when disciplines connect, and ideas converge. The event also highlighted the depth of talent, innovation, and scientific curiosity across India's rapidly evolving research ecosystem. By bringing together expertise from academia and research we create opportunities to accelerate discovery and move closer to what matters most: improving outcomes for patients.
1
4
208
A sincere thank you to all our speakers, researchers, and participants for sharing their insights, challenging perspectives, and contributing to the rich exchange of ideas that made THE RISING 2026 such a valuable platform for scientific dialogue. As we look ahead, one thing is clear: the future of medicine will be shaped not by any one discipline, but by the power of collaboration across them. #BRRising2026 #BiomedicalResearch #Innovation #AIInHealthcare #ReimaginingMedicine #NovartisIndia
103
AI is not just a commitment at Novartis India. It is becoming an integral part of how we reimagine medicine every day. Recently, we brought this spirit to life through our AI F(AI)R across India offices, receiving an impressive 328 AI use case submissions from colleagues across the organization. Following a rigorous evaluation process, 22 finalist teams showcased innovative solutions demonstrating how AI can advance patient-centricity, strengthen collaboration, and enhance operational excellence. Through interactive exhibits and engaging conversations, colleagues explored the projects firsthand and exchanged ideas on the future of AI-enabled innovation. We were also privileged to hear insights from our Chief Guest, Dr. Rama Iyer, Head of Innovation, GMR Group, on unlocking the transformative potential of AI. Congratulations to all participants, finalists, winners, and the team that earned the People's Choice Award through employee voting. The enthusiasm, creativity, and collaboration on display reaffirm a shared belief: when cutting-edge technology meets human ingenuity, we can unlock new possibilities for patients. Together, we continue to harness the power of AI, science, and innovation to reimagine from India what is possible for patients, everywhere. #NovartisIndia #ReimaginingMedicineInIndia #AIinHealthcare #InnovationInAction #ArtificialIntelligence #ReimaginingMedicine
3
185
At Novartis, we believe that innovation flourishes where people, purpose, and possibility come together. The inauguration of our newly developed workspace represents more than a physical space. It reflects our continued investment in fostering a culture of collaboration, learning, and innovation in India, a market that is increasingly shaping the future of science and healthcare. By creating environments that enable our associates to connect and innovate, we are strengthening the foundation for breakthroughs that can ultimately benefit patients around the world. #NovartisIndia #Innovation #Collaboration #ReimaginingMedicine
4
176
What helps unlock a nation's potential as a global healthcare innovation hub? Building an environment where science and innovation can thrive. During her visit to India, Judith Love, President, Asia Pacific, Middle East and Africa at Novartis, shared her perspective on the importance of fostering an innovation-enabling ecosystem that can accelerate medical progress and attract long-term investment. A critical component of such an ecosystem is Regulatory Data Protection (RDP). By providing greater certainty for innovators and recognizing the value of scientific research, RDP can help create conditions that encourage continued investment in R&D and support the discovery of new medicines for patients. India is uniquely positioned to shape the future of healthcare innovation. With world-class scientific talent, a rapidly evolving research landscape, strong clinical capabilities and a growing focus on innovation, the country has many of the foundations needed to drive the next wave of medical breakthroughs. Strengthening policies that support innovation can further accelerate research, enable greater collaboration, and help ensure that patients gain timely access to the benefits of scientific advancement. Because when innovation is nurtured and protected, the possibilities for patients, science, and society are limitless. #ReimaginingMedicine #NovartisIndia #HealthcareInnovation #RegulatoryDataProtection #BusinessStandard #India
1
140
Chronic Spontaneous Urticaria (CSU) is an unpredictable skin condition that causes persistent itching and hives, but its impact can go far beyond the skin. In line with global prevalence, an estimated 14 million (1%) people in India are living with #CSU.¹ CSU can disrupt sleep and affect daily life. For many people, when symptoms flare, everyday activities including work can sometimes take more effort than usual. This #UDAY2026, we are proud to support UCARE 4U's activities to highlight the experience of people living with CSU and encourage open conversations. Talk to your doctor about how CSU is affecting your sleep, work, and overall quality of life. #TakeBackControl and start the conversation. Learn more here: novartis.com/diseases/chroni… 1. Godse, K et al (2022) Management of chronic spontaneous urticaria: Real-world Indian perspective. Indian Journal of skin allergy. skinallergyjournal.com/manag… doi: 10.25259/IJSA_4_2021 FA-11806181/03-10-2026/ 2 Years #UrticariaDay2026 #WorldUrticariaDay #HealthcareAwareness #TurnItIntoUnderstanding #ChronicUrticaria #PatientVoice #QualityOfLifre #MentalHealth #Empathy
2
165
This #WorldHeartDay, we are reminded of a sobering reality: cardiovascular disease remains the world’s leading cause of death. But behind every statistic is a human life, and high LDL Cholesterol is a risk factor we can actively manage. Knowing your LDL Cholesterol number, understanding what it means for your health, and having informed conversations with your healthcare professional are vital steps toward protecting your heart. Through science, innovation, and collaboration, we are committed to transforming cardiovascular care and building a future where fewer lives are cut short. No Heart Lost Too Soon. #WorldHeartDay #DontMissABeat #HeartHealth #CardiovascularDisease #NoHeartLostTooSoon
83
CML is a form of blood cancer affecting the adults and rarely in children with an annual incidence of approximately 2 cases per 100000 people.¹ For those living with it, however, treatment can be part of a much longer journey. It is about managing the disease while continuing to pursue the things that matter, from work and family to personal wellbeing and everyday life. As our understanding of CML evolves, so do the goals of treatment. Advances in care have expanded treatment goals beyond disease control to include deeper molecular responses, preservation of quality of life and the possibility of treatment-free remission for some eligible patients.
1
1
206
At Novartis, we listen to the experiences and needs of people living with CML and continue to advance science with these priorities in mind. By reimagining medicine, we continue to support research aimed at improving outcomes and addressing unmet needs in CML. 1. Elias Jabbour, Hagop Kantarjian (2025) Chronic Myeloid Leukemia: A Review. pubmed.ncbi.nlm.nih.gov/4009… #CMLDay #ReimaginingMedicineInIndia
156